C. Illueca et al., Prognostic factors in Barrett's esophagus: an immunohistochemical and morphometric study of 120 cases, REV ESP E D, 92(11), 2000, pp. 732-737
Barrett's esophagus is a condition in which the squamous mucosa that normal
ly lines the distal esophagus is replaced by a columnar type of epithelium.
Although it carries a clear risk of adenocarcinoma, the estimation of this
risk and therefore the value of endoscopic screening remain highly controv
ersial.
AIM: to investigate more sensitive techniques to identify those patients wh
o are at high risk of developing cancer and who need intensive endoscopic s
urveillance for early detection.
METHODS: a morphologic, histochemical and morphometric study was performed
on paraffin-embedded material from 120 patients with Barrett's esophagus an
d 18 with adenocarcinoma. In addition, each sample was analyzed immunohisto
chemically with proliferating cell nuclear antigen (PCNA), p53, c-erbB-2, C
EA and EMA antibodies.
RESULTS: in all zones of the glandular mucosa we found a higher percentage
of PCNA-positive nuclei when the specialized epithelium was present. We saw
PCNA expression in 75% of the patients with adenocarcinoma, and p53 expres
sion in 15% of the patients without dysplasia, 37% of the patients with dys
plasia and 44% of the patients with adenocarcinoma. Positivity for c-erbB-2
was found in 38% of the patients without dysplasia, 53% of those with dysp
lasia and 37% of those with adenocarcinoma. Aneuploidy was found in 70% of
the patients with metaplasia or dysplasia and in all patients with adenocar
cinoma.
CONCLUSIONS: we conclude that p53, PCNA overexpression and aneuploidy are m
arkers of risk for malignancy in Barrett's esophagus.